Restek Wins Company of the Year
Restek has been awarded company of the year by The Pennsylvania/Delaware Chapter of the ESOP Association during its annual conference on 14 September 2017.
Restek has been awarded company of the year by The Pennsylvania/Delaware Chapter of the ESOP Association during its annual conference on 14 September 2017.
Restek has previously won the award in 2007 with many Restek employees attending ESOP conferences throughout the years as session speakers.
Jeff Gelburd, ESOP Association Chapter President, said, “Employees at Restek are fully engaged in the ownership culture. They also have done wonderful work in advocacy both in Pennsylvania and in Washington D.C.”
“Restek is very deserving of this award and should be a top contender to win the national award at The ESOP Association meeting next May,” added Gelburd. An employee stock ownership plan (ESOP) is a business structure in which the employees of the company are also owners. Restek transitioned to 100% ESOP on 31 December 2008.
Bryan Wolcott, Restek President and Head Coach, said, “Restek is a family-oriented company that is owned by its employees. While our business is scientific, our culture is all about teamwork and taking care of our fellow employees so that we can better serve our customers and our community. We are honoured to be recognized by the ESOP Association and encouraged to continue serving others through our business, our charity, and our ESOP advocacy.”
For more information please visit, www.restek.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
